The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Zverev N.P.

I.P. Pavlov Ryazan State Medical University of the Ministry of Health of Russia

Lyakhovets A.A.

I.P. Pavlov Ryazan State Medical University of the Ministry of Health of Russia

Plaksa I.L.

Moscow City Oncology Hospital No. 62;
Human Stem Cell Institute

Khmelkova D.N.

OOO «GENETICO» Center of Genetics and Reproductive Medicine

Isaev A.A.

OOO «GENETICO» Center of Genetics and Reproductive Medicine

Metastatic basal cell carcinoma with a SMO gene mutation. A case report

Authors:

Zverev N.P., Lyakhovets A.A., Plaksa I.L., Khmelkova D.N., Isaev A.A.

More about the authors

Journal: Russian Journal of Archive of Pathology. 2021;83(6): 35‑38

DOI: 10.17116/patol20218306135

Read: 2150 times

Download PDF (RU)
Contact the author
Table of contents

METASTATIC BASAL CELL CARCINOMA WITH A SMO GENE MUTATION. A CASE REPORT
METASTATIC BASAL CELL CARCINOMA WITH A SMO GENE MUTATION. A CASE REPORT

To cite this article:

Zverev NP, Lyakhovets AA, Plaksa IL, Khmelkova DN, Isaev AA. Metastatic basal cell carcinoma with a SMO gene mutation. A case report. Russian Journal of Archive of Pathology. 2021;83(6):35‑38. (In Russ.)
https://doi.org/10.17116/patol20218306135

Подписка 2026 Архив патологии (Russian Journal of Archive of Pathology)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Schi­zophrenic spectrum diso­rders and Parkinson’s disease. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(3):136-141
A rare case of endo­metrial stro­mal sarcoma of the cervix and vagina in a 17-year-old patient with abno­rmal uterine bleeding. Russian Journal of Human Reproduction. 2025;(2):86-91
Sellar collision tumors: difficulties of preoperative neuroimaging and sele­ction of surgical approach. Case repo­rts and lite­rature review. Burdenko's Journal of Neurosurgery. 2025;(3):75-82
Mela­noma of the maxi­llary sinus mucosa. Stomatology. 2025;(2):82-85
Genome instability of the cholera agent: role in the evolution of pathogenicity, drug resi­stance and adaptation to a changing envi­ronment. Mole­cular Gene­tics, Microbiology and Viro­logy. 2025;(2):3-13
Febrile infe­ction-related epilepsy syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7):34-40
A case of the vaso­spastic angina deve­lopment due to acute myocarditis in the patient. Russian Journal of Preventive Medi­cine. 2025;(8):102-109
A clinical case of treating a patient with severe ischemic stroke and cancer. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):114-117
A clinical case of surgical treatment of a large odontogenic kera­tocyst. Stomatology. 2025;(4):93-97
Justification of the effe­ctiveness of the use of biomimetic extracellular matrix preparation in one-stage implantation. Russian Journal of Stomatology. 2025;(3):19-25
Abstract:

The authors describe a clinical case of a patient with metastatic basal cell carcinoma and secondary resistance to vismodegib. A SMO G416E mutation of unknown clinical significance was found in the gene encoding the transmembrane receptor protein Smoothened (SMO) protein, which suggests a defect in the Sonic Hedgehog (SH) pathway and may cause tumor resistance to the prescribed drug. Comprehensive genomic profiling and in silico analysis have been used to diagnose the tumor.

Keywords:

SMO
G416E
vismodegib
Sonic Hedgehog
basal cell carcinoma
resistance
clinical case

Authors:

Zverev N.P.

I.P. Pavlov Ryazan State Medical University of the Ministry of Health of Russia

Lyakhovets A.A.

I.P. Pavlov Ryazan State Medical University of the Ministry of Health of Russia

Plaksa I.L.

Moscow City Oncology Hospital No. 62;
Human Stem Cell Institute

Khmelkova D.N.

OOO «GENETICO» Center of Genetics and Reproductive Medicine

Isaev A.A.

OOO «GENETICO» Center of Genetics and Reproductive Medicine

Received:

02.06.2021

Accepted:

17.09.2021

Close metadata

References:

  1. Bisceglia M, Panniello G, Galliani CA, et al. Metastatic basal cell carcinoma of the skin: a comprehensive literature review, including advances in molecular therapeutics. Adv Anat Pathol. 2020;27(5):331-353. PMID: 32618586. https://doi.org/10.1097/PAP.0000000000000267
  2. Von Domarus H, Stevens PJ. Metastatic basal cell carcinoma. Report of five cases and review of 170 cases in the literature. J Am Acad Dermatol. 1984;10:1043-1060.
  3. Kopanos C, Tsiolkas V, Kouris A, Chapple CE, Albarca Aguilera M, Meyer R, Massouras A. VarSome: The Human Genomic Variant Search Engine. Bioinformatics. 2019;35:1978-1980. https://doi.org/10.1093/bioinformatics/bty897
  4. Kumar V, Abbas AK, Fausto N, Aster DzhK. Osnovy patologii zabolevaniy po Robbinsu i Kotranu. M.: Logosphera; 2016.
  5. Sekulic A, Migden MR, Basset-Séguin N, et al. Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study. BMC Cancer. 2017;17(1):332. 
  6. Meiss F, Andrlová H, Zeiser R. Vismodegib. Recent Results. Cancer Res. 2018;211:125-139.  https://doi.org/10.1007/978-3-319-91442-8_9
  7. Casey D, Demko S, Shord S, Zhao H, Chen H, He K, Putman A, Helms W, Keegan P, Pazdur R. FDA Approval Summary: Sonidegib for Locally Advanced Basal Cell Carcinoma. Clin Cancer Res. 2017;23:2377-2381. https://doi.org/10.1158/1078-0432.CCR-16-2051
  8. Sekulic A, Migden MR, Oro AE, Dirix L, Lewis KD, Hainsworth JD, Solomon JA, Yoo S, Arron ST, Friedlander PA, et al. Efficacy and safety of vismodegib in advanced basal-cell carcinoma. N Engl J Med. 2012;366:2171-2179. https://doi.org/10.1056/NEJMoa1113713
  9. Sekulic A, Migden MR, Basset-Seguin N, Garbe C, Gesierich A, Lao CD, Miller C, Mortier L, Murrell DF, Hamid O, et al. Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: Final update of the pivotal ERIVANCE BCC study. BMC Cancer. 2017;17:332.  https://doi.org/10.1186/s12885-017-3286-5
  10. Chang AL, Oro AE. Initial assessment of tumor regrowth after vismodegib in advanced basal cell carcinoma. Arch Dermatol. 2012;148(11):1324132-5. 
  11. Yauch RL, Dijkgraaf GJ, Alicke B, et al. Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma. Science. 2009;326:572-574.  https://doi.org/10.1126/science.1179386
  12. Pricl S, Cortelazzi B, Dal Col V, et al. Smoothened (SMO) receptor mutations dictate resistance to vismodegib in basal cell carcinoma. Mol Oncol. 2015;9(2):389-397.  https://doi.org/10.1016/j.molonc.2014.09.003
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.